✦ LIBER ✦

Prevalence of abnormal liver function and hepatitis B antigenemia in hepatitis B antibody positive kidney transplant patients

✍ Scribed by U Luvira; I Kanjanakul; S Kuvanont

Book ID: 117229574
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 61 KB
Volume: 32
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(00)01501-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Hepatitis B Core Antibody-Positiv

Use of Hepatitis B Core Antibody-Positive Donor Kidneys in Hepatitis B Surface Antibody-Positive and -Negative Recipients

✍ M. Veroux; C. Puliatti; M. Gagliano; D. Cappello; M. Macarone; D. Vizcarra; M. S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Outcomes of hepatitis C- and hepatitis B

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation

✍ Sammy Saab; Albert J. Chang; Scott Comulada; Sunil K. Geevarghese; R. Dean M. An 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Recurrence of hepatocellular carcinoma a

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantation

✍ Sammy Saab; Melina Yeganeh; Kelvin Nguyen; Francisco Durazo; Steven Han; Hasan Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Hepatitis B virus (HBV) reinfection and recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT) are associated with increased graft failure and reduced patient survival. We evaluated the effects of both HCC recurrence and HBV reinfection on the long-term survival of

Reactivation of hepatitis B virus with m

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen– and antibody to hepatitis B core antigen–positive donor

✍ Annette Blaich; Michael Manz; Alexis Dumoulin; Christian G. Schüttler; Hans H. H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 317 KB

High risk of hepatitis B-virus reactivat

High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients

✍ Kosei Matsue; Takatoshi Aoki; Jun Odawara; Hideaki Fujiwara; Kan-ichi Iwama; Shu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Long-term lamivudine monotherapy prevent

Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors

✍ Emilia Prakoso; Simone I. Strasser; David J. Koorey; Deborah Verran; Geoffrey W. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB